9-3
Uber to cut 3,300 jobs worldwide, affecting Australian staff
Uber says it will cut 3,300 jobs globally, about 3% of its workforce, as it moves to streamline its cost base. The company says it will reinvest the savings in autonomous-vehicle efforts, including more than $US10 billion in commitments. In Australia, Uber generated more than A$14.5 billion in revenue last year and A$2.12 billion in gross profit, but most was paid out as service fees to overseas related companies. That left the local business with a net profit of A$8.7 million.
9-3
9-2
Wall Street slips as oil jumps and Treasury yields rise; ASX futures point to 78-point drop
Another round of US military strikes on Iran pushed oil prices higher, renewing concerns that inflation will remain stubborn. With inflation still above 3%, markets increasingly expect the Federal Reserve to raise interest rates before year-end, with the implied probability of a September hike rising to 66%. Higher oil and rate expectations weighed on risk appetite, dragging major US stock indexes lower.
9-2
8-31
Wall Street edges lower as Warsh reiterates 2% inflation goal; ASX futures point to 36-point drop
Federal Reserve Chair Kevin Warsh struck a hawkish tone, reiterating his commitment to bringing inflation down to the Fed’s 2% target even if it causes short-term pain for the economy. Rate-hike expectations rose, sending the two-year US Treasury yield up to 4.35% from 4.22% ahead of the speech. US stocks slipped modestly, as investors viewed the remarks as reinforcing the Fed’s credibility in its inflation fight.
8-31
8-28
Nvidia, Salesforce earnings lift Wall Street; ASX futures point to 0.2% rise
Technology stocks led U.S. shares higher as companies such as Nvidia and Salesforce posted spring earnings that beat analysts’ expectations. With the Federal Reserve offering limited guidance on the future path of interest rates, investors are watching its next steps to bring inflation under control. Oil prices also climbed, with Brent crude up 1.8% to $88.52. ASX futures signalled a modestly higher open.
8-28
8-25
Eli Lilly completes $US7.8 billion Centessa deal, drawing attention to orexin drugs for narcolepsy
Eli Lilly has completed a $US7.8 billion acquisition of Centessa, which is developing experimental therapies for rare sleep disorders. The deal has drawn market attention and is seen by some as expanding the imagination around potential “human-enhancement” uses for orexin-targeting medicines. Lilly is the world’s most valuable pharmaceutical company with a $US1.1 trillion market capitalisation, buoyed by the rise of GLP1 weight-loss drugs.
8-25
8-24
Nevada court files detail Murdoch trust bid to secure Lachlan’s control of News and Fox
A Nevada probate court has released a 96-page decision describing an effort led by Lachlan Murdoch’s deputy, Siobhan McKenna, to alter the Murdoch family trust deed to keep control of News Corp and Fox Corp with Lachlan. Lachlan Murdoch and Rupert Murdoch later paid $5 billion for James, Prudence and Elisabeth Murdoch to give up their voting rights in the trust. The settlement left News Corp able to maintain its existing editorial direction.
8-24